|Find A PhysicianHome | Library | PRIME | Newsroom | A-Z Guide | E-mail | Contact Us | Directions|
Raavi Gupta, MD
Division of Surgical Pathology and Hematopathology
Office location: A2-406A
e-mail: Raavi.Gupta @downstate.edu
Research or Clinical Interest Summary
My main interest is in the field of hematopathology, particularly studying myelodysplastic syndrome. I am also involved in hematology and coagulation laboratory.
Selected Recent Publications
Clinicopathologic Features of B-Cell Post-Transplant Lymphoproliferative Disorders Occurring in Lymphoid Tissue of the Waldeyers Ring. D Baiyee, R Gupta, B Alobeid, G Bhagat Modern Pathology 2007; 20 suppl;233A
Percentage hematogones by flow cytometry analysis is lower in patients with myelodysplastic syndrome than in cytopenic patients without myelodysplastic syndrome. R Gupta, RP Hasserjian, WN Rezuke, JA Diuseppe, JP Hunt. Modern Pathology 2006; 19:suppl1: 23A.
Myelodysplastic Syndrome with Isolated Del(20q): a Distinct Clinicopathologic Entity? R Gupta, V Johari, R Hasserjian. Modern Pathology 2006; 19:suppl1: 229A.
Evaluation of the relationships between pAKT and Beta-catenin in Invasive breast carcinoma. RSJ Ricketts, R Gupta, SI Camelo, D Arbadjief, M Arbadjief, B Pacik, S Marconi, CN Otis. Modern Pathology 2006;19:suppl1:40A
Evaluation of the PI3K/pAkt Pathway in Breast carcinoma which Are negative for ER, PR and Her-2/neu Receptor expression. RSJ Ricketts, R Gupta B Pacik, S Marconi, CN Otis. Modern Pathology 2006; 19:suppl1: 40A.
Evaluation of Phospho-mTOR ( Mamalian Target of Rapamycin) Expression in Benign, Proliferative and Malignant Epithelial Lesions of the breast. SI Camelo, R Rickets, DA Arbadjief, MA Arbadjief, R Gupta, B Pacik, S Marconi, CN Otis. Modern Pathology 2006;19:suppl1:23A.
pAKT/PI3K over expression May Predict Poor Survival in Patients Treated with Herceptin for 3+ HER-2/neu Positive Breast Carcinoma. R Gupta, R St J Ricketts, S Marconi, CN Otis. Modern Pathology 2006; 18:suppl1: 35A.